Sort   by:  
 Page size 
Genomicsena-DATASET-VIB-08-06-2015-13:42:05:930-599 - samples
Description not provided
EGAD00001001391 | EGA
GenomicsPLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
EGAS00001001281 | EGA
GenomicsVIB VRC Data Access Committee
Data Access Committee EGAC00001000042
EGAC00001000042 | EGA
TranscriptomicsMetastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features [aCGH]
Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Sixty f...
ORGANISM(S): Homo sapiens 
2014-07-31 | E-GEOD-54183 | biostudies-arrayexpress
TranscriptomicsMetastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features [transcriptome]
Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Sixty f...
ORGANISM(S): Homo sapiens 
2014-07-31 | E-GEOD-54187 | biostudies-arrayexpress
Sort   by:  
 Page size